Renamed to PhenomeX Inc. (NASDAQ:CELL) in May 2023
BLI - Berkeley Lights, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
EmeryVille,
United States
Type: Equity
BLI price evolution
BLI
| (in millions $) | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $86.52 | $120.64 | $143.02 | $164.94 |
| Short term investments | $46.25 | $14.07 | $9.36 | |
| Net receivables | $19.82 | $20.25 | $13.81 | $17.72 |
| Inventory | $18.86 | $15.71 | $15.66 | $15.66 |
| Total current assets | $176.95 | $180.96 | $192.47 | $208.36 |
| Long term investments | ||||
| Property, plant & equipment | $47.17 | $51.82 | $53.84 | $55.24 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $49.14 | $53.92 | $56.24 | $57.49 |
| Total investments | $46.25 | $14.07 | $9.36 | |
| Total assets | $226.09 | $234.88 | $248.71 | $265.86 |
| Current liabilities | ||||
| Accounts payable | $10.09 | $7.92 | $8.5 | $8.02 |
| Deferred revenue | $10.05 | $9.17 | $9.91 | $11.38 |
| Short long term debt | $4.97 | $2.48 | ||
| Total current liabilities | $45.49 | $34.38 | $29.14 | $27.71 |
| Long term debt | $14.86 | $40.89 | $43.93 | $43.34 |
| Total noncurrent liabilities | $38.55 | $42.32 | $45.15 | $44.95 |
| Total debt | $42.55 | $43.37 | $43.93 | $43.34 |
| Total liabilities | $84.04 | $76.7 | $74.29 | $72.66 |
| Shareholders' equity | ||||
| Retained earnings | -$361.65 | -$332.35 | -$310.78 | -$285.03 |
| Other shareholder equity | -$0.01 | -$0.02 | -$0.02 | |
| Total shareholder equity | $142.06 | $158.18 | $174.42 | $193.2 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $86.52 | $178.37 | $233.68 | $81.3 |
| Short term investments | $46.25 | |||
| Net receivables | $19.82 | $25.94 | $12.94 | $9.33 |
| Inventory | $18.86 | $14.55 | $11.05 | $7.18 |
| Total current assets | $176.95 | $230.57 | $265.57 | $105.35 |
| Long term investments | ||||
| Property, plant & equipment | $47.17 | $54.05 | $31.26 | $24.26 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $49.14 | $56.68 | $34.09 | $25.66 |
| Total investments | $46.25 | |||
| Total assets | $226.09 | $287.25 | $299.66 | $131.01 |
| Current liabilities | ||||
| Accounts payable | $10.09 | $8.2 | $3.49 | $3.24 |
| Deferred revenue | $10.05 | $14.31 | $7.19 | $11.15 |
| Short long term debt | $4.97 | $11.59 | $5.76 | |
| Total current liabilities | $45.49 | $32.75 | $28.97 | $24.92 |
| Long term debt | $14.86 | $44.1 | $24.2 | $20.85 |
| Total noncurrent liabilities | $38.55 | $46.29 | $25.91 | $22.31 |
| Total debt | $42.55 | $44.1 | $35.79 | $26.61 |
| Total liabilities | $84.04 | $79.04 | $54.88 | $47.23 |
| Shareholders' equity | ||||
| Retained earnings | -$361.65 | -$263.61 | -$191.88 | -$150.3 |
| Other shareholder equity | -$0.01 | $224.77 | ||
| Total shareholder equity | $142.06 | $208.22 | $244.78 | $83.78 |
| (in millions $) | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $17.84 | $21.4 | $19.15 | $20.21 |
| Cost of revenue | $5.84 | $6.37 | $6.22 | $6.38 |
| Gross Profit | $12 | $15.03 | $12.93 | $13.83 |
| Operating activities | ||||
| Research & development | $8.48 | $8.98 | $18.18 | $17.57 |
| Selling, general & administrative | $30.77 | $26.52 | $20.3 | $17.53 |
| Total operating expenses | $41.7 | $36.56 | $38.47 | $35.1 |
| Operating income | -$29.7 | -$21.54 | -$25.55 | -$21.27 |
| Income from continuing operations | ||||
| EBIT | -$29.02 | -$21.32 | -$25.52 | -$21.18 |
| Income tax expense | $0.05 | $0.02 | $0 | $0.02 |
| Interest expense | $0.23 | $0.23 | $0.23 | $0.22 |
| Net income | ||||
| Net income | -$29.3 | -$21.57 | -$25.75 | -$21.43 |
| Income (for common shares) | -$29.3 | -$21.57 | -$25.75 | -$21.43 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $78.59 | $85.39 | $64.3 | $56.69 |
| Cost of revenue | $24.81 | $28.84 | $19.75 | $13.22 |
| Gross Profit | $53.78 | $56.55 | $44.55 | $43.48 |
| Operating activities | ||||
| Research & development | $53.21 | $58.55 | $47.24 | $38.41 |
| Selling, general & administrative | $95.11 | $68.79 | $37.71 | $21.6 |
| Total operating expenses | $151.84 | $127.34 | $84.95 | $60.01 |
| Operating income | -$98.05 | -$70.79 | -$40.39 | -$16.54 |
| Income from continuing operations | ||||
| EBIT | -$97.03 | -$70.61 | -$39.97 | -$16.81 |
| Income tax expense | $0.1 | -$0.06 | $0.17 | $0.07 |
| Interest expense | $0.91 | $1.17 | $1.44 | $1.43 |
| Net income | ||||
| Net income | -$98.04 | -$71.72 | -$41.58 | -$18.3 |
| Income (for common shares) | -$98.04 | -$71.72 | -$41.58 | -$18.3 |
| (in millions $) | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Net income | -$29.3 | -$21.57 | -$25.75 | -$21.43 |
| Operating activities | ||||
| Depreciation | $3.22 | $2.94 | $3.29 | $2.68 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.05 | $5.18 | $6.57 | $5.39 |
| Total cash flows from operations | -$10.04 | -$16.91 | -$10.52 | -$10.07 |
| Investing activities | ||||
| Capital expenditures | -$0.34 | -$0.97 | -$2.38 | -$4.38 |
| Investments | -$31.86 | -$4.67 | -$9.37 | |
| Total cash flows from investing | -$32.21 | -$5.64 | -$11.76 | -$4.38 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $8.13 | $0.18 | $0.35 | $1.02 |
| Net borrowings | ||||
| Total cash flows from financing | $8.13 | $0.18 | $0.35 | $1.02 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$34.12 | -$22.38 | -$21.92 | -$13.42 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$98.04 | -$71.72 | -$41.58 | -$18.3 |
| Operating activities | ||||
| Depreciation | $12.12 | $7.92 | $6.79 | $6.51 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $22.19 | $21.22 | $10.92 | $3.76 |
| Total cash flows from operations | -$47.54 | -$53.13 | -$35.85 | -$10.53 |
| Investing activities | ||||
| Capital expenditures | -$8.08 | -$15.82 | -$3.29 | -$8.42 |
| Investments | -$45.91 | -$0.65 | ||
| Total cash flows from investing | -$53.98 | -$15.82 | -$3.29 | -$9.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $9.68 | $13.94 | $194.17 | $1.02 |
| Net borrowings | -$0.3 | |||
| Total cash flows from financing | $9.68 | $13.64 | $191.52 | $1.02 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$91.84 | -$55.31 | $152.38 | -$18.58 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 72.17M |
| Revenue | $78.59M |
|---|---|
| EBITDA | -$84.91M |
| EBIT | -$97.03M |
| Net Income | -$98.04M |
| Revenue Q/Q | -23.05% |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 1.97 |
| Cash/Share | 1.20 |
| EPS | -$1.36 |
|---|---|
| ROA | -40.20% |
| ROE | -58.72% |
| Debt/Equity | 0.59 |
|---|---|
| Net debt/EBITDA | 0.03 |
| Current ratio | 3.89 |
| Quick ratio | 3.48 |